Research priorities towards precision antibiotic therapy to improve patient care

ZP Bulman, SG Wicha, EI Nielsen, JR Lenhard… - The Lancet …, 2022 - thelancet.com
Antibiotic resistance presents an incessant threat to our drug armamentarium that
necessitates novel approaches to therapy. Over the past several decades, investigation of …

Multidrug resistance (MDR) and collateral sensitivity in bacteria, with special attention to genetic and evolutionary aspects and to the perspectives of antimicrobial …

A Fodor, BA Abate, P Deák, L Fodor, E Gyenge… - Pathogens, 2020 - mdpi.com
Antibiotic poly-resistance (multidrug-, extreme-, and pan-drug resistance) is controlled by
adaptive evolution. Darwinian and Lamarckian interpretations of resistance evolution are …

Structural characterization of the D179N and D179Y variants of KPC-2 β-lactamase: Ω-loop destabilization as a mechanism of resistance to ceftazidime-avibactam

TA Alsenani, SL Viviani, V Kumar… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
Klebsiella pneumoniae carbapenemases (KPC-2 and KPC-3) present a global clinical
threat, as these β-lactamases confer resistance to carbapenems and oxyimino …

Carbapenem and colistin resistance in Enterobacter: determinants and clones

Z Zong, Y Feng, A McNally - Trends in microbiology, 2021 - cell.com
Enterobacter is a globally important pathogen. Here we clarify its taxonomy and review
recent developments in its resistance to carbapenem and colistin, illustrating that …

The whole is bigger than the sum of its parts: drug transport in the context of two membranes with active efflux

VV Rybenkov, HI Zgurskaya, C Ganguly… - Chemical …, 2021 - ACS Publications
Cell envelope plays a dual role in the life of bacteria by simultaneously protecting it from a
hostile environment and facilitating access to beneficial molecules. At the heart of this ability …

Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales

M Biagi, M Lee, T Wu, A Shajee, S Patel… - … and Infectious Disease, 2022 - Elsevier
Objective The objective of this study was to evaluate the in vitro activity of aztreonam plus
imipenem-relebactam against clinical and isogenic strains of Escherichia coli and Klebsiella …

Penicillin-Binding Protein 5/6 Acting as a Decoy Target in Pseudomonas aeruginosa Identified by Whole-Cell Receptor Binding and Quantitative Systems …

S López-Argüello, M Montaner… - Antimicrobial agents …, 2023 - Am Soc Microbiol
The β-lactam antibiotics have been successfully used for decades to combat susceptible
Pseudomonas aeruginosa, which has a notoriously difficult to penetrate outer membrane …

Mechanistic insights to combating NDM-and CTX-M-coproducing Klebsiella pneumoniae by targeting cell wall synthesis and outer membrane integrity

NM Smith, KR Boissonneault, L Chen… - Antimicrobial agents …, 2022 - Am Soc Microbiol
ABSTRACT Metallo-β-lactamase (MBL)-producing Gram-negative bacteria cause infections
associated with high rates of morbidity and mortality. Currently, a leading regimen to treat …

First penicillin-binding protein occupancy patterns for 15 β-lactams and β-lactamase inhibitors in Mycobacterium abscessus

ARM Sayed, NR Shah, KB Basso… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Mycobacterium abscessus causes serious infections that often require over 18 months of
antibiotic combination therapy. There is no standard regimen for the treatment of M …

In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates

Q Zhang, N Neidig, TY Chu, C Divoky… - … and infectious disease, 2022 - Elsevier
Cefiderocol, a siderophore-containing cephalosporin with broad-spectrum antimicrobial
activity against many β-lactam-resistant Gram-negative bacteria, was tested by broth …